Company intelligence / Profile preview

PrecisionBiotics

Cork, Cork, Irelandprecisionbiotics.science ↗

Ownership: Private
Development stage: Other

Overview

Multiple proprietary probiotic strains have demonstrated clinical efficacy in managing IBS symptoms, improving stress resilience and anxiety reduction, supporting vaginal health, with additional preclinical data in immune support. Products are validated by robust clinical studies primarily in the UK and Europe.

Therapeutic areas: Infectious DiseasesPsychiatryGastroenterologyWomen's Health
Modalities: Live biotherapeutic product therapy (probiotics)Microbial therapy
Industry: Biotech

Drug pipeline

1 asset

lactobacillus gasseri LBV150

Unknown

Partnerships

APC Microbiome Institute at University College CorkNovozymes R&D networkHuman Health Centres of Excellence worldwide

Beyond the preview

Go deeper on PrecisionBiotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PrecisionBiotics.

Explore the full profile